Syngene International Ltd.
Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is India’s largest Contract Research Organization offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies.
Our service offerings in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates (“ADC”) and oligonucleotides. Our integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage. We are also in the process of setting up a large scale manufacturing facility at Mangalore to strengthen our commercial manufacturing services.
Syngene brings together a state-of-the-art infrastructure spread across 1.3 Mn sq. ft. and a highly experienced team of about 3100 scientists, to help R&D focused organizations achieve better R&D efficiency and reduce development time. For more details, visit www.syngeneintl.com.
|Sales markets||Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Central/South America|
|Affiliated categories:||API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More|
Meet us at
Our Top products
Small & large molecule Discovery & Development
Discovery Chemistry, Discovery Biology, Integrated Drug DiscoveryMore info
Integrated Drug Substance-Drug Product development
Process R&D, Custom manufacturing, formulation development, Clinical supplies, safety assessmentMore info
News about Syngene International Ltd.
9 Oct 2017
Syngene International Announces Broadening of Research Collaboration with Amgen Inc.
With the expansion, the floor space of Syngene Amgen Research & Development Center will double to 50,000 sq. ft. A team of up to 185 multi-disciplinary Syngene scientists will work in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.Read more
Categories affiliated with Syngene International Ltd.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation